Your session is about to expire
← Back to Search
Behavioural Intervention
VR System for Cross-modal Rehabilitation of Hemianopia
N/A
Waitlist Available
Led By Huai Jiang, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* Adult volunteers diagnosed with homonymous visual hemianopia / hemianopsia (ages 18-99)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 2 months, 3 months
Awards & highlights
No Placebo-Only Group
Summary
The purpose of this research study is to investigate the effectiveness of a new rehabilitation for visual hemianopia. The study team believes a cross-modal rehabilitation technique delivered by a virtual reality system can help restore the visual field for subjects with homonymous hemianopia.
Eligible Conditions
- Homonymous Hemianopia
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 2 months, 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 2 months, 3 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Humphrey Visual Field Perimetry
Peripheral Visual Field Frame Test
Virtual Reality (VR) Visual Field Test--Mean Percent Correct
+1 moreSecondary study objectives
NEI-VFQ-25--Color Vision Score Subscale
NEI-VFQ-25--Composite Score
NEI-VFQ-25--Dependency Score Subscale
+15 moreOther study objectives
Color Vision Test
Grating Acuity Test
Shape Recognition Test
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Experimental Group Virtual Reality (VR) TreatmentExperimental Treatment1 Intervention
Visual Auditory Virtual Reality rehabilitation for visual hemianopia
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cross-model Visual Auditory Rehabilitation
2020
N/A
~10
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,397 Previous Clinical Trials
2,460,123 Total Patients Enrolled
Huai Jiang, PhDPrincipal InvestigatorWake Forest University Health Sciences